Article
Modeling disease progression and placebo response in Huntington's Disease: Insights from Enroll-HD and GENERATION HD1 cohorts
2024-02-17
Abstract excerpt
<h4>Objective: </h4> The objective of this study was to quantify longitudinal changes in Unified Huntington's Disease Rating Scale (UHDRS) clinical scores and evaluate their susceptibility to placebo response, improving our understanding of disease progression and the ability to optimize clinical trials in Huntington's disease. <h4>Methods:</h4> We utilized data from the Enroll-HD and GENERATION HD1 placebo arm co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 69582e1f-3d8b-5fa8-a693-c7da5a0854de
- DOI
- 10.1101/2024.02.15.24302445
